{
    "Trade/Device Name(s)": [
        "Lyra\u2122 Parainfluenza Virus Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K141927",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091053"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OOU"
    ],
    "Summary Letter Date": "July 15, 2014",
    "Summary Letter Received Date": "July 16, 2014",
    "Submission Date": "July 15, 2014",
    "Regulation Number(s)": [
        "21CFR866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Human parainfluenza virus type 1",
        "Human parainfluenza virus type 2",
        "Human parainfluenza virus type 3"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx",
        "bioM\u00e9rieux NucliSENS easyMAG"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex RT-PCR",
        "Nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Lyra\u2122 Parainfluenza Virus Assay, a multiplex RT-PCR test for qualitative detection and identification of human parainfluenza virus types 1, 2, and 3 RNA in nasal and nasopharyngeal swab specimens.",
    "Indications for Use Summary": "Qualitative detection and identification of human parainfluenza virus types 1, 2, and 3 RNA in nasal and nasopharyngeal swab specimens from symptomatic patients, aiding differential diagnosis; not intended to detect Parainfluenza 4a or 4b viruses.",
    "fda_folder": "Microbiology"
}